ONUREG

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug ONUREG contains one active pharmaceutical ingredient (API):

1 Azacitidine UNII M801H13NRU - AZACITIDINE

Azacitidine is believed to exert its antineoplastic effects by multiple mechanisms including cytotoxicity on abnormal haematopoietic cells in the bone marrow and hypomethylation of DNA. The cytotoxic effects of azacitidine may result from multiple mechanisms, including inhibition of DNA, RNA and protein synthesis, incorporation into RNA and DNA, and activation of DNA damage pathways. Read about Azacitidine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ONUREG Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC07	Azacitidine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1852275, 1852286, 1852297, 1852309
Country: FR	Base de données publique des médicaments	Identifier(s): 64799168, 67694966
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9047, 9048
Country: IT	Agenzia del Farmaco	Identifier(s): 049620014, 049620026, 049620038, 049620040
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092904, 1092905, 1092906, 1092907
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100455330, 100455348
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67898001, W67899001
Country: US	FDA, National Drug Code	Identifier(s): 59572-730, 59572-740